The development comes against the backdrop of unapproved Indian-made drugs being exported to countries in Africa and being ...

Michael Dong recently discussed sample preparation (SP) techniques for small-molecule drug substances and solid dosage forms.

Discover Q1 2025 earnings insights from Cellectar Biosciences (CLRB), focusing on regulatory progress for iopofosine I 131, strategic alternatives, ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

CROs Advance Pharmaceutical Innovation with Thermo Fisher Scientific In today’s fast-paced pharmaceutical landscape, Contract ...

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.